Bauer S - Search Results

1

Emerging Agents for the Treatment of Advanced, Imatinib-Resistant Gastrointestinal Stromal Tumors: Current Status and Future Directions.

Bauer S, Joensuu H. Bauer S, et al. Drugs. 2015 Aug;75(12):1323-34. doi: 10.1007/s40265-015-0440-8. Drugs. 2015. PMID: 26187774 Free PMC article. Review.

2

Imatinib mesylate therapy in patients with gastrointestinal stromal tumors and impaired liver function.

Bauer S, Hagen V, Pielken HJ, Bojko P, Seeber S, Schütte J. Bauer S, et al. Anticancer Drugs. 2002 Sep;13(8):847-9. doi: 10.1097/00001813-200209000-00010. Anticancer Drugs. 2002. PMID: 12394270

3

Response to imatinib mesylate of a gastrointestinal stromal tumor with very low expression of KIT.

Bauer S, Corless CL, Heinrich MC, Dirsch O, Antoch G, Kanja J, Seeber S, Schütte J. Bauer S, et al. Cancer Chemother Pharmacol. 2003 Mar;51(3):261-5. doi: 10.1007/s00280-002-0564-x. Epub 2003 Feb 26. Cancer Chemother Pharmacol. 2003. PMID: 12655446

4

Comparison of PET, CT, and dual-modality PET/CT imaging for monitoring of imatinib (STI571) therapy in patients with gastrointestinal stromal tumors.

Antoch G, Kanja J, Bauer S, Kuehl H, Renzing-Koehler K, Schuette J, Bockisch A, Debatin JF, Freudenberg LS. Antoch G, et al. Among authors: bauer s. J Nucl Med. 2004 Mar;45(3):357-65. J Nucl Med. 2004. PMID: 15001674 Free article. Clinical Trial.

5

Resection of residual disease in patients with metastatic gastrointestinal stromal tumors responding to treatment with imatinib.

Bauer S, Hartmann JT, de Wit M, Lang H, Grabellus F, Antoch G, Niebel W, Erhard J, Ebeling P, Zeth M, Taeger G, Seeber S, Flasshove M, Schütte J. Bauer S, et al. Int J Cancer. 2005 Nov 1;117(2):316-25. doi: 10.1002/ijc.21164. Int J Cancer. 2005. PMID: 15900603 Free article. Clinical Trial.

6

Locally advanced and metastatic sarcoma (adult type) including gastrointestinal stromal tumors.

Bauer S, Hartmann JT. Bauer S, et al. Crit Rev Oncol Hematol. 2006 Nov;60(2):112-30. doi: 10.1016/j.critrevonc.2006.06.010. Epub 2006 Sep 1. Crit Rev Oncol Hematol. 2006. PMID: 16949832 Review.

7

Heat shock protein 90 inhibition in imatinib-resistant gastrointestinal stromal tumor.

Bauer S, Yu LK, Demetri GD, Fletcher JA. Bauer S, et al. Cancer Res. 2006 Sep 15;66(18):9153-61. doi: 10.1158/0008-5472.CAN-06-0165. Cancer Res. 2006. PMID: 16982758

8

The challenge of opportunities: how far can and should we go with targeted treatments and modern diagnostics in gastrointestinal stromal tumors?

Bauer S, Lang H. Bauer S, et al. Eur J Gastroenterol Hepatol. 2007 Aug;19(8):619-22. doi: 10.1097/MEG.0b013e328011392d. Eur J Gastroenterol Hepatol. 2007. PMID: 17625429 Review.

9

Inhibitors of deacetylases suppress oncogenic KIT signaling, acetylate HSP90, and induce apoptosis in gastrointestinal stromal tumors.

Mühlenberg T, Zhang Y, Wagner AJ, Grabellus F, Bradner J, Taeger G, Lang H, Taguchi T, Schuler M, Fletcher JA, Bauer S. Mühlenberg T, et al. Among authors: bauer s. Cancer Res. 2009 Sep 1;69(17):6941-50. doi: 10.1158/0008-5472.CAN-08-4004. Epub 2009 Aug 25. Cancer Res. 2009. PMID: 19706776 Free PMC article.

10

Proapoptotic activity of bortezomib in gastrointestinal stromal tumor cells.

Bauer S, Parry JA, Mühlenberg T, Brown MF, Seneviratne D, Chatterjee P, Chin A, Rubin BP, Kuan SF, Fletcher JA, Duensing S, Duensing A. Bauer S, et al. Cancer Res. 2010 Jan 1;70(1):150-9. doi: 10.1158/0008-5472.CAN-09-1449. Epub 2009 Dec 22. Cancer Res. 2010. PMID: 20028860 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,521 results

Search Page